EurActiv Logo
EU news & policy debates
- across languages -
Bulgaria News
Turkey News
Germany News
Spain News
France News
United Kingdom News
Poland News
Czech Republic News
Slovakia News
Hungary News
Romania News
Serbia News
Greece News
Italy News
Bulgaria Turkey Germany Spain France United Kingdom Poland Czech Republic Slovakia Hungary Romania Serbia Greece Italy
EurActiv.com Network

BROWSE ALL SECTIONS

Commission calls for changes in drugs patent rules for developing countries

Published 07 March 2002 - Updated 29 January 2010
Printer-friendly versionSend to friend

The EU has presented a proposal to the WTO concerning access to medicines for developing countries that do not have the capacity to produce them themselves.

On 5 March 2002, the WTO Council on Trade-Related Aspects of Intellectual Property Rights (TRIPS) met in Geneva. The EU presented its proposal as to how the patent agreement should be modified to support countries that cannot themselves produce the drugs. The EU suggests amendments to Articles 30 and 31f of the TRIPS agreement, to allow for medicines to be produced elsewhere and exported under "compulsory licensing" to the country in need. The export would need to be strictly controlled to ensure that the drugs do not reach other markets.

 

Next steps: 
The TRIPS Council must report to the WTO General Council before the end of 2002.

 

Background: 
At the WTO negotiations in Doha in November 2001, an agreement was reached to ease patent rules to allow developing countries to produce patented drugs under a procedure called "compulsory licensing". This way countries struck by health crise such as HIV, are given access to affordable medicines. (see also EurActiv13 November 2001)

 

Advertising